Status:
ENROLLING_BY_INVITATION
The Use of Smart Glasses for Saphenous Nerve Adductor Canal Block
Lead Sponsor:
MetroHealth Medical Center
Conditions:
Total Knee Arthroplasty
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The use of smart glasses for saphenous nerve adductor canal blocks compared to standard of care.
Eligibility Criteria
Inclusion
- patients 18 years or greater
- undergoing total knee arthroplasty
Exclusion
- Patients with local infection at nerve block site
- BMI \>40
- Patients who are at risk for local anesthesia systemic toxicity due to intraoperative local dose
- Patients with nerve damage to the femoral or saphenous nerve
- Documented history of mental or cognitive disabilities in EMR
- Non-English speaking patient
- Pregnant Women (self-reported)
- Prisoners
- Patients under the age of 18
Key Trial Info
Start Date :
March 4 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07213622
Start Date
March 4 2024
End Date
February 1 2026
Last Update
October 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MetroHealth Hospital
Cleveland, Ohio, United States, 44109